We describe here the direct synthesis of novel gluconamidoalkyl methacrylamides by reacting D ‐gluconolactone with aminoalkyl methacrylamides. The glycomonomers were then successfully polymerized via the reversible addition‐fragmentation chain transfer process (RAFT) using 4‐cyanopentanoic acid dithiobenzoate (CTP) as chain transfer agent and 4,4′‐azobis(4‐cyanovaleric acid) (ACVA) as the initiator in aqueous media. Well‐defined polymers were obtained as revealed by gel permeation chromatography. Diblock copolymers were then synthesized by the macro‐CTA approach. The cationic glycopolymers were subsequently used in the formation of nanostructures via the complexation with plasmid DNA. As noted by dynamic light scattering, monodisperse nanoparticles were obtained via the electrostatic interaction of the cationic glycopolymer with DNA. The sizes of the nanoparticles formed were found to be stable and independent of pH. In vitro cell viability studies of the glycopolymers were carried out using HELA cell lines. The RAFT synthesized glycopolymers and cationic glyco‐copolymers revealed to be nontoxic.
No takes yet. Share an insight, caveat, or question.
Deng et al. (2008) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: